Get started
Author

Sampath Peddapelli

Observed names: Peddapelli, Sampath, Sampath peddapelli
Institution: Chaitanya
ORCID: 0009-0001-1949-3306
Observed ORCID: 0009-0001-1949-3306
OpenAlex ID: A5117262638
New quinazoline-[1,2,4]triazolo[3,4- b ][1,3,4]thiadiazines as inhibitors of EGFR: synthesis, anti-breast cancer evaluation and in silico studies
2025 · Mahadev Dattatray Bandgar, Sampath Peddapelli, et al. · RSC Medicinal Chemistry · 11
Synthesis of Quinazoline‐1,3,4‐Oxadiazole Linked 1,2,3‐Triazole Hybrids as Potent EGFR Targeting Antilung Cancer Agents: In Vitro, In Silico, and DFT Studies
2025 · Sampath peddapelli, Mahadev Dattatray Bandgar, et al. · ChemistrySelect · 5
Design, synthesis, molecular docking, and biological evaluation of Piperazine–Oxadiazole–Quinazoline hybrids as potential EGFR inhibitors for Lung cancer therapy
2026 · Mahadev Dattatray Bandgar, Sampath Peddapelli, et al. · Chemical Biology Letters
PDF
Synthesis and anticancer evaluation of novel quinazoline- piperazine linked 1,2,3-triazoles as potent Multi target anti-cancer agents
2026 · Sirassu Narsimha, Sampath Peddapelli, et al. · SSRN Electronic Journal
Author response for "New quinazoline-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of EGFR: synthesis, anti-breast cancer evaluation and in silico studies"
2025 · Bandgar, Mahadev Dattatray, Peddapelli, Sampath, et al. · Publons reviews and discussion
Author response for "New quinazoline-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of EGFR: synthesis, anti-breast cancer evaluation and in silico studies"
2025 · Bandgar, Mahadev Dattatray, Peddapelli, Sampath, et al. · Publons reviews and discussion
Works count: 6
Citation count: 16
H-index: 2
I10-index: 1
Year
Topic
Type